UroMed launching Impress Softpatch female incontinence device in early 1998, company tells analysts.
This article was originally published in The Gray Sheet
Executive Summary
UROMED LAUNCHING IMPRESS SOFTPATCH FEMALE URINARY INCONTINENCE DEVICE in the U.S. the first half of 1998 following scale up of manufacturing at the firm's Needham, Massachusetts facility. The single-use, soft foam patch device, which gained 510(k) clearance in mid-1996, is applied using a gel-adhesive strip to the labia of a patient to prevent urinary leakage.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.